# EDGAR Filing Document

**Accession Number:** 0001453593
**File Stem:** 0001790300-25-000005
**Filing Date:** 2025-8
**Character Count:** 10882
**Document Hash:** 015a248f2e544cfda57bc93030314e99
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001790300-25-000005.hdr.sgml**: 20250808

**ACCESSION NUMBER**: 0001790300-25-000005

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250801

**FILED AS OF DATE**: 20250808

**DATE AS OF CHANGE**: 20250808

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lipschultz Tyler
- **CENTRAL INDEX KEY:** 0001509284

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-34951
- **FILM NUMBER:** 251198714

**MAIL ADDRESS:**
- **STREET 1:** 664 CRUISER LANE
- **CITY:** BELGRADE
- **STATE:** MT
- **ZIP:** 59714
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Xtant Medical Holdings, Inc.
- **CENTRAL INDEX KEY:** 0001453593
- **STANDARD INDUSTRIAL CLASSIFICATION:** SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 205313323
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 664 CRUISER LANE
- **CITY:** BELGRADE
- **STATE:** MT
- **ZIP:** 59714
- **BUSINESS PHONE:** 406-388-0480

**MAIL ADDRESS:**
- **STREET 1:** 664 CRUISER LANE
- **CITY:** BELGRADE
- **STATE:** MT
- **ZIP:** 59714

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Bacterin International Holdings, Inc.
- **DATE OF NAME CHANGE:** 20100615

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** K KITZ INC
- **DATE OF NAME CHANGE:** 20090108

## Ex-24

```

POWER OF ATTORNEY
TYLER LIPSCHULTZ

With respect to holdings of and transactions in securities
issued by Xtant Medical Holdings, Inc. (the Company), the
undersigned hereby constitutes and appoints each of the
individuals listed on Schedule A attached hereto and as
may be amended from time to time, or any of them acting
singly, and with full power of substitution and
re-substitution, as the undersigned's true and lawful
attorney-in-fact (each of such persons and their substitutes
being referred to herein as the Attorney-in-Fact), with
full power to act for the undersigned and in the
undersigned's name, place and stead, in any and all
capacities, to:

1.  Prepare, execute and submit to the United States
Securities and Exchange Commission (SEC) a Form ID,
including amendments thereto, and any other documents
necessary or appropriate to obtain codes and passwords
enabling the undersigned to make electronic filings with
the SEC of reports required or considered by the Attorney-
in-Fact to be advisable under Section 13 or Section 16 of
the United States Securities Exchange Act of 1934, as
amended (the Exchange Act), or any rule or regulation of
the SEC, including without limitation enrolling the
undersigned in the SEC's EDGAR Next system if the
undersigned is not already enrolled in such system;

2.  Do and perform any and all acts for and on behalf
of the undersigned which may be necessary to prepare,
execute and submit to the SEC, the Company and or any
national securities exchange on which the Company's
securities are listed any and all reports the undersigned
is required to file with the SEC, or which the Attorney-
in-Fact considers advisable to file with the SEC, under
Section 13 or Section 16 of the Exchange Act or any
rule or regulation thereunder, or Rule 144 (Rule 144)
under the United Stated Securities Act of 1933, as
amended, and the rules and regulations thereunder, with
respect to any security of the Company, including Forms
3, 4 and 5, Schedules 13D and 13G, and Forms 144
(including any amendments thereto, the SEC Filings);

3.  Obtain, as the undersigned's representative and on
the undersigned's behalf, information regarding
transactions in the Company's equity securities from any
third party, including the Company and any brokers,
dealers, employee benefit plan administrators and
trustees, and the undersigned hereby authorizes any
such third party to release any such information to
the Attorney-in-Fact.

4.  Serve as the point of contact for the undersigned's
SEC EDGAR and EDGAR Next filing codes;

5.  Serve as the undersigned's account administrator
o the SEC's EDGAR Next platform, which responsi-
bilities may include, but are not limited to,
managing and updating the undersigned's account as
needed, serving as a point of contact for the SEC
Staff, completing the undersigned's annual account
confirmation and authorizing and de-authorizing
other account administrators, users, delegated
entities or technical administrators, which may
make SEC filings on the undersigned's behalf; and

6.  Take any other action of any time whatsoever in
connection with the foregoing which, in the opinion of
such Attorney-in-Fact, may be of benefit to, in the best
interest of, or legally required by, the undersigned, it
being understood that the documents executed by such
Attorney-in-Fact on behalf of the undersigned pursuant
to this Power of Attorney shall be in such form and shall
contain such terms and conditions as such Attorney-in-Fact
may approve in the discretion of such Attorney-in-Fact.

The undersigned acknowledges that:

a)  This Power of Attorney authorizes, but does not
require, the Attorney-in-Fact to act in his or her
discretion on information provided to such Attorney-in-
Fact without independent verification of such
information;

b)  Any documents prepared or executed by Attorney-in-
Fact on behalf of the undersigned pursuant to this Power
of Attorney will be in such form and will contain such
information as the Attorney-in-Fact, in his or her dis-
creation, deems necessary or desirable;

c)  Neither the Company nor the Attorney-in-Fact assumes
any liability for the undersigned's responsibility to
comply with the requirements of Section 13 or Section
16 of the Exchange Act or Rule 144, any liability of
the undersigned for any failure to comply with such
requirements, or any liability of the undersigned for
disgorgement of profits under Section 16(b) of the
Exchange Act; and

d)  This Power of Attorney does not relieve the under-
signed from responsibility for compliance with the
undersigned's obligations under Section 13 or Section
16 of the Exchange Act, including, without limitation,
the reporting requirements under Section 13 or Section
16 of the Exchange Act.

The undersigned hereby grants to the Attorney-in-Fact
full power and authority to do and perform each and
every act and thing whatsoever requisite, necessary
or advisable to be done in the exercise of any of the
rights and powers herein granted, as fully, to all
intents and purposes, as the undersigned might or
could do in person, with full power of substitution
and re-substitution or revocation, hereby ratifying
and confirming all that such Attorney-in-Fact, or such
Attorney-in-Fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this
Power of Attorney and the rights and powers herein
granted.

This Power of Attorney shall remain in full force and
effect until the undersigned is no longer required to
file SEC Filings with respect to the undersigned's
holdings of and transactions in securities of the
Company, unless earlier revoked by the undersigned
in a signed writing delivered to the Attorney-in-Fact.

IN WITNESS WHEREOF, the undersigned has executed this
Power of Attorney as of this 4th day of August 2025.

/s/ Tyler Lipschultz
Tyler Lipschultz

NOTARIZATION

State of CA
County of San Diego

This Power of Attorney was acknowledged before me
on [DATE] Aug 4, 2025 by [NAME OF NOTARY] Justin J.
Mansour.

/s/ Justin J. Mansour
Notary Signature

[NOTARY SEAL]

--------------------------------------------------------
Schedule A

Individuals Appointed as Attorney-in-Fact with Full Power
of Substitution and Re-substitution

1.  Sean Browne, President and Chief Executive Officer
of the Company

2.  Scott Neils, Chief Financial Officer of the
Company

3.  Amy Culbert, Fox Rothschild LLP

4.  Emily Humbert, Fox Rothschild LLP

5.  Deanna Counsell, Fox Rothschild LLP

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lipschultz Tyler<br><sub>(Last) (First) (Middle)</sub><br>664 CRUISER LANE<br><sub>(Street)</sub><br>BELGRADE, MT 59714<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>Xtant Medical Holdings, Inc. [ XTNT ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2025-08-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director   [ ] 10% Owner<br>[ ] Officer (give title below)   [ ] Other (specify below)<br>_ _ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |

---

**Remarks:**
Exhibit List - Exhibit No. 24 - Power of Attorney

**Signature:** /s/ Amy E. Culbert, attorney-in-fact  
**Date:** 2025-08-08

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**